Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 20/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 18/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27997201 | 0.76 | SLC6A4 (0.74) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL3518627 | 0.76 | SLC6A3 (1.00) | SLC6A3SLC6A4SLC6A2 | |
| Hydrochloric Acid SCHEMBL1375 | 0.76 | SLC6A4 (0.66) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL16691398 | 0.75 | SLC6A4 (0.70) | SLC6A3SLC6A4SLC6A2 | |
| Hydrochloric Acid SCHEMBL10840117 | 0.75 | SLC6A3 (0.96) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL3519378 | 0.75 | SLC6A3 (1.00) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL8242202 | 0.75 | SLC6A3 (1.00) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL8243516 | 0.74 | SLC6A4 (1.00) | SLC6A3SLC6A4SLC6A2 | |
| Hydrochloric Acid SCHEMBL3517560 | 0.73 | SLC6A3 (0.97) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL16521001 | 0.73 | SLC6A4 (0.94) | SLC6A3SLC6A4SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0828484-A1 | USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY | Knoll AG (DE) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038134-A1 | USE OF ARYL SUBSTITUTED CYCLOBUTYL ALKYL AMINES FOR THE TREATMENT OF OBESITY | KNOLL AG (DE) | 1996-12-05 | — | — | WO | disclosed |